Platelet-to-Lymphocyte Ratio as a Predictor of Atrial Fibrillation in STEMI Patients

12 June 2025 : Clinical Research

Tingting Li^{BCDEF 1}, Qi Zhang^{BCDEF 2}, Xiaosong Gu^{BE 3}, Yifei Tao^{AEF 4*}, Jiayu Yin^{ABCDEF 3}

DOI: 10.12659/MSM.948334

Med Sci Monit 2025; 31:e948334

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions Data Availability Statement References

Related articles Order reprints Share article Share by email

View HTML version

Table 4 Multivariate logistic regression analysis for NOAF.

	β	S.E	Wald χ2	OR (95% CI)	P
LVEF	−0.105	0.020	26.534	0.900 (0.865~0.937)	<0.001
PLR	0.003	0.001	8.351	1.003 (1.001~1.006)	0.004
NT-proBNP	0.422	0.134	9.948	1.525 (1.173~1.982)	0.002
NOAF – new-onset atrial fibrillation; LVEF – left ventricular ejection fraction; NT-proBNP – N-terminal pro-B-type natriuretic peptide; NOAF – new-onset atrial fibrillation; PLR – platelet-to-lymphocyte ratio.

Back to the Article